BUDGET IMPACT OF NIRAPARIB AS MAINTENANCE TREATMENT FOR MEDICARE PATIENTS WITH RECURRENT OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER WHO ARE IN COMPLETE OR PARTIAL RESPONSE TO PLATINUM-BASED CHEMOTHERAPY

被引：0
|
作者：
Neeser, K. [1 ]
O'Neil, W. M. [1 ]
Stern, L. [1 ]
机构：
[1] Analyt Laser, New York, NY USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.129
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN51
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [21] PHASE I/II STUDY OF CARBOPLATIN AND PRALATREXATE IN PATIENTS WITH RECURRENT PLATINUM SENSITIVE OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER
    del Carmen, M.
    Campos, S.
    Krasner, C.
    Berlin, S.
    Supko, J.
    Atkinson, T.
    Birrer, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 419 - 420
  • [22] Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer
    Shih, K. K.
    Chi, D. S.
    Barakat, R. R.
    Leitao, M. M.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S104 - S104
  • [23] Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer
    Shih, K. K.
    Chi, D. S.
    Barakat, R. R.
    Leitao, M. M., Jr.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 364 - 369
  • [24] Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer.
    Swetzig, Wendy M.
    Lurain, John Robert
    Berry, Emily
    Pineda, Mario Javier
    Shahabi, Shohreh
    Perry, La Toya
    Neubauer, Nikki Lynn
    Nieves-Neira, Wilberto
    Schink, Julian C.
    Schiller, Alissa
    Novak, Karen
    Anderson, Nancy Jean
    Burdett, Kirsten Bell
    Strohl, Anna Everett
    Kocherginsky, Masha
    Matei, Daniela
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [25] Efficacy and safety of olaparib maintenance monotherapy for Japanese patients with platinum-sensitive relapsed ovarian, fallopian tube, and primary peritoneal cancer
    Tomoko Yoshihama
    Yuka Kuroda
    Tatsuyuki Chiyoda
    Mio Takahashi
    Takuma Yoshimura
    Keiko Saotome
    Yoshiko Nanki
    Kensuke Sakai
    Yusuke Kobayashi
    Wataru Yamagami
    Daisuke Aoki
    International Journal of Clinical Oncology, 2022, 27 : 1644 - 1650
  • [26] Efficacy and safety of olaparib maintenance monotherapy for Japanese patients with platinum-sensitive relapsed ovarian, fallopian tube, and primary peritoneal cancer
    Yoshihama, Tomoko
    Kuroda, Yuka
    Chiyoda, Tatsuyuki
    Takahashi, Mio
    Yoshimura, Takuma
    Saotome, Keiko
    Nanki, Yoshiko
    Sakai, Kensuke
    Kobayashi, Yusuke
    Yamagami, Wataru
    Aoki, Daisuke
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (10) : 1644 - 1650
  • [27] Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy
    Shin Nishio
    Noriyuki Katsumata
    Koji Matsumoto
    Hiroshi Tanabe
    Kan Yonemori
    Tsutomu Kouno
    Chikako Shimizu
    Masashi Ando
    Toshiharu Kamura
    Takahiro Kasamatsu
    Yasuhiro Fujiwara
    Journal of Cancer Research and Clinical Oncology, 2009, 135
  • [28] Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy
    Nishio, S.
    Katsumata, N.
    Matsumoto, K.
    Tanabe, H.
    Yonemori, K.
    Fujiwara, Y.
    Ushijima, K.
    Kamura, T.
    EJC SUPPLEMENTS, 2009, 7 (02): : 459 - 459
  • [29] Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy
    Nishio, Shin
    Katsumata, Noriyuki
    Matsumoto, Koji
    Tanabe, Hiroshi
    Yonemori, Kan
    Kouno, Tsutomu
    Shimizu, Chikako
    Ando, Masashi
    Kamura, Toshiharu
    Kasamatsu, Takahiro
    Fujiwara, Yasuhiro
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (04) : 551 - 557
  • [30] Phase 1 and 2 Study of Carboplatin and Pralatrexate in Patients With Recurrent, Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    del Carmen, Marcela G.
    Supko, Jeff G.
    Horick, Nora K.
    Rauh-Hain, J. Alejandro
    Clark, Rachel M.
    Campos, Susana M.
    Krasner, Carolyn N.
    Atkinson, Tina
    Birrer, Michael J.
    CANCER, 2016, 122 (21) : 3297 - 3306
12345